Home › Patheon Expands Early Development Offerings and Capacity At U.K. Facility
 

Keywords :   


Patheon Expands Early Development Offerings and Capacity At U.K. Facility

2014-01-16 17:36:30| drugdiscoveryonline News Articles

Patheon's investment in early development capabilities in Europe means expanded capacity for handling highly potent compounds in the early pharmaceutical development phases at the Milton Park facility and then feeding into the later stage and commercialization capabilities at a site in Bourgoin, France.

Tags: development uk early capacity

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
21.09Strategies to minimize fallback pigs in the nursery
21.09This Week in Agribusiness, Sept. 21, 2024
21.09This Week in Agribusiness, Sept. 21, 2024
21.09RABapp provides rapid response insight in animal health emergencies
21.09Atlantic Tropical Weather Outlook
21.09Eastern North Pacific Tropical Weather Outlook
More »